Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/IIa Study of PET/CT Imaging Using INR101 Injection in Healthy Male Subjects and Patients With Suspected Prostate Cancer

NCT06472531 is registered in ClinicalTrials.gov with Yunhe Pharmaceutical (Tianjin) Co., Ltd as lead sponsor.

NCT NCT06472531
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06472531 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/IIa Study of PET/CT Imaging Using INR101 Injection in Healthy Male Subjects and Patients With Suspected Prostate Cancer
Lead sponsor
Yunhe Pharmaceutical (Tianjin) Co., Ltd
Phase
Phase 1/2
Overall status
Completed
Start date
May 23, 2024
Completion date
October 10, 2024
Enrollment
32 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy male subjects, suspected prostate cancer